Contract 1448604

The Nebraska Department of Veterans Affairs has awarded a contract to McKesson Drug Company, headquartered in Dallas, Texas, effective July 16, 2026, with a completion date of January 1, 2099. This contract, identified as 1448604, carries a contract value of $9,753.75 and is classified under contract type ZO. The extended performance period spanning over 72 years indicates a long-term service agreement typical of standing supply or framework arrangements within the veterans affairs sector.

McKesson Drug Company will serve as the prime contractor responsible for delivering pharmaceutical and related healthcare products or services to support the Nebraska Department of Veterans Affairs' operations. While specific locations of performance are not detailed in the award documentation, the contract duration and value structure suggest an ongoing supply or distribution arrangement. The relatively modest contract amount in relation to the extended performance timeline indicates this award may represent either an initial phase, a renewal of an existing agreement, or a specialized, limited-scope supply contract for the department's veteran services operations.